DXC Technology Company (DXC): From Top to Bottom

DXC Technology Company (DXC) is an interesting player in the Technology space, with a focus on Information Technology Services. The stock has been active on the tape, currently trading at $84.69, down from yesterday’s close by -0.25%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

DXC Technology Company (DXC) currently trades with a market capitalization of $24.19 Billion. That value represents a market adjusting for revenues that have been growing by 233.19 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of $ over the past twelve months. Generally speaking, earnings are expected to grow in coming quarters. Analysts are forecasting earnings of $1.76 on a per share basis this quarter. Perhaps, that suggests something about why 0.75% of the outstanding share supply is held by institutional investors.

Technical Analysis

We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, DXC Technology Company recorded a 52-week high of $93.28. It is now trading 8.59% off that level. The stock is trading $98.57 its 50-day moving average by 13.88%. The stock carved out a 52-week low down at $63.58.

In recent action, DXC Technology Company (DXC) has made a move of -17.44% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 14.11, and it’s gotten there by action that has been less volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.97% with $283.61 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of DXC.

Previous articleTaking a Fresh Look at Onconova Therapeutics, Inc. (ONTX)
Next articleDrilling Down Into Delek US Holdings, Inc. (DK)